Olema Pharmaceuticals Inc (OLMA)

03:30 AM

JPMorgan Chase & Co. Buys 157,171 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

03:30 AM

Jan 19, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Holdings Increased by Hennion & Walsh Asset Management Inc. - MarketBeat

Jan 19, 2025

Jan 16, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $27.00 Consensus Target Price from Brokerages - MarketBeat

Jan 16, 2025

Jan 16, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jan 16, 2025

Jan 15, 2025

Form 424B5 Olema Pharmaceuticals, - StreetInsider.com

Jan 15, 2025

Jan 14, 2025

Barclays PLC Purchases 48,614 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jan 14, 2025

Jan 13, 2025

Bain Capital Life Sciences Investors, LLC Acquires Significant Stake in Olema Pharmaceuticals Inc - GuruFocus.com

Jan 13, 2025

Jan 13, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Major Shareholder Acquires $1,728,000.00 in Stock - MarketBeat

Jan 13, 2025

Jan 13, 2025

Bain Capital Life Sciences buys $1.7m in Olema Pharmaceuticals stock - Investing.com Nigeria

Jan 13, 2025

Jan 11, 2025

Olema Pharmaceuticals announces equity security exchange By Investing.com - Investing.com Australia

Jan 11, 2025

Jan 11, 2025

Olema Pharmaceuticals announces equity security exchange - Investing.com India

Jan 11, 2025

Jan 10, 2025

Olema Pharmaceuticals stock hits 52-week low at $5.02 - Investing.com India

Jan 10, 2025

Jan 10, 2025

Olema Pharmaceuticals stock hits 52-week low at $5.02 By Investing.com - Investing.com South Africa

Jan 10, 2025

Jan 06, 2025

(OLMA) Investment Report - Stock Traders Daily

Jan 06, 2025

Jan 03, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jan 03, 2025

Jan 03, 2025

Olema Pharmaceuticals Awards New Employee Stock Options for Cancer Drug Development Team - StockTitan

Jan 03, 2025

Jan 02, 2025

Olema Pharmaceuticals stock hits 52-week low at $5.55 By Investing.com - Investing.com Australia

Jan 02, 2025

Jan 02, 2025

Olema Pharmaceuticals stock hits 52-week low at $5.55 - Investing.com India

Jan 02, 2025

Jan 02, 2025

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 02, 2025

Jan 01, 2025

Geode Capital Management LLC Decreases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jan 01, 2025

Jan 01, 2025

Geode Capital Management LLC Sells 125,170 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Jan 01, 2025

Dec 30, 2024

Barclays PLC Acquires 48,614 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Dec 30, 2024

Dec 28, 2024

Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateForm 8-K - Marketscreener.com

Dec 28, 2024

Dec 23, 2024

Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion - MSN

Dec 23, 2024

Dec 23, 2024

State Street Corp Boosts Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Dec 23, 2024

Dec 22, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of “Buy” by Brokerages - Defense World

Dec 22, 2024

Dec 22, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of "Buy" by Brokerages - MarketBeat

Dec 22, 2024

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 7,616 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Dec 20, 2024

Dec 18, 2024

Top 3 Health Care Stocks That May Explode In Q4 - Benzinga

Dec 18, 2024

Dec 18, 2024

Olema Pharmaceuticals director Graham Walmsley sells $4.73m in stock By Investing.com - Investing.com Australia

Dec 18, 2024

Dec 17, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Director Sells $4,730,136.75 in Stock - MarketBeat

Dec 17, 2024

Dec 17, 2024

Olema Pharmaceuticals director Graham Walmsley sells $4.73m in stock - Investing.com

Dec 17, 2024

Dec 16, 2024

(OLMA) Technical Pivots with Risk Controls - Stock Traders Daily

Dec 16, 2024

Dec 15, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by Wellington Management Group LLP - MarketBeat

Dec 15, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Dec 15, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Buys 207,565 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Dec 15, 2024

Dec 14, 2024

What is HC Wainwright’s Forecast for OLMA FY2024 Earnings? - Defense World

Dec 14, 2024

Dec 13, 2024

What is HC Wainwright's Estimate for OLMA FY2024 Earnings? - MarketBeat

Dec 13, 2024

Dec 13, 2024

Olema Pharmaceuticals stock hits 52-week low at $7.67 By Investing.com - Investing.com Canada

Dec 13, 2024

Dec 12, 2024

Olema Pharmaceuticals stock hits 52-week low at $7.67 - Investing.com India

Dec 12, 2024

Dec 12, 2024

Olema Pharmaceuticals CEO Sean Bohen sells shares worth $986,365 By Investing.com - Investing.com Nigeria

Dec 12, 2024

Dec 12, 2024

Olema Pharmaceuticals, Inc. announced that it has received $249.999225 million in funding from a group of investors - Marketscreener.com

Dec 12, 2024

Dec 12, 2024

Olema Pharmaceuticals director sells shares worth $147,955 By Investing.com - Investing.com Nigeria

Dec 12, 2024

Dec 11, 2024

Olema Pharmaceuticals CEO Sean Bohen sells shares worth $986,365 - Investing.com

Dec 11, 2024